MarkHMossMD
Allergy & Immunology • Madison, WIAsthma & Allergic Conditions
Associate Professor, Medicine, University of Wisconsin Medical School
Are you Dr. Moss?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 60 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
600 Highland Ave
Madison, WI 53792Phone+1 608-263-6180Fax+1 608-263-9103
Summary
- Dr. Mark Moss, MD is an allergist/immunologist in Madison, Wisconsin. He is currently licensed to practice medicine in Wisconsin. He is affiliated with University Hospital and UnityPoint Health Meriter.
Education & Training
University of Wisconsin Hospitals and ClinicsFellowship, Allergy and Immunology, 1998 - 2000- University of Wisconsin Hospitals and ClinicsResidency, Pediatrics, 1994 - 1998
University of Wisconsin School of Medicine & Public HealthClass of 1994
Certifications & Licensure
WI State Medical License 1996 - 2025- American Board of Allergy and Immunology Allergy & Immunology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011
Clinical Trials
- Anti-TSLP (AMG 157) Plus Antigen-Specific Immunotherapy for Induction of Tolerance in Individuals With Cat Allergy Start of enrollment: 2015 Mar 03
Publications & Presentations
PubMed
- 28 citationsEffects of combination treatment with tezepelumab and allergen immunotherapy on nasal responses to allergen: A randomized controlled trial.Jonathan Corren, David Larson, Matthew C Altman, R Max Segnitz, Pedro C Avila
The Journal of Allergy and Clinical Immunology. 2023-01-01 - 1 citationsA 2-week medical student curriculum in an outpatient allergy clinic.Daniel L Rosenberg, Mark H Moss, Sarah K Johnson, Fauzia Osman
Annals of Allergy, Asthma & Immunology. 2022-10-01 - 4 citationsResults of a Phase 2b Trial With GB001, a Prostaglandin DReceptor 2 Antagonist, in Moderate to Severe Eosinophilic Asthma.Mark H Moss, Njira L Lugogo, Mario Castro, Nicola A Hanania, Andrea Ludwig-Sengpiel
Chest. 2022-08-01
Press Mentions
Could My Baby Be Lactose Intolerant?September 21st, 2018
Sudden Rise in Pollen Exposure Catches Allergy Sufferers by SurpriseJune 2nd, 2018- Weather Changes May Aggravate Those Prone to AllergiesSeptember 28th, 2017
- Join now to see all
Professional Memberships
- Member
